Zenas Biopharma (ZBIO) PT Lowered to $48 at Jefferies, 'we see clear path for approval (BLA submission planned in 2Q and MAA in 2H26')

Go back to Zenas Biopharma (ZBIO) PT Lowered to $48 at Jefferies, 'we see clear path for approval (BLA submission planned in 2Q and MAA in 2H26')
(NASDAQ: ZBIO) Delayed: 29.20 -2.09 (6.68%)
Previous Close $31.29    52 Week High $50.95 
Open $30.39    52 Week Low $18.06 
Day High $31.00    P/E N/A 
Day Low $27.81    EPS $0.00 
Volume 881,512